Compile Data Set for Download or QSAR
maximum 50k data
Found 1669 with Last Name = 'harriott' and Initial = 'n'
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611939((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-{[(1R,2R)- ...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611952((2R,3R,11bR)-9- (cyclobutylmethoxy)-3-(2,2- dimeth...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611867(1-(2-{[(2R,3R,11bR)-3-(2,2- dimethylpropyl)-2-hydr...)
Affinity DataKi:  0.410nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611873((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(3- fluorop...)
Affinity DataKi:  0.480nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611905((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  0.520nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611877((2R,3R,11bR)-9-cyclobutoxy- 3-(2,2-dimethylpropyl)...)
Affinity DataKi:  0.590nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611937((2R,3R,11bR)-9- (cyclopropylmethoxy)-3-(2,2- dimet...)
Affinity DataKi:  0.680nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611954((2R,3R,11bR)-9-[(2,2- difluorocyclopropyl)methoxy]...)
Affinity DataKi:  0.820nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611906((2R,3R,11bR)-9-{[1- (difluoromethyl)cyclo- propyl]...)
Affinity DataKi:  0.930nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611872((2R,3R,11bR)-9-cyclopropoxy- 3-(2,2-dimethylpropyl...)
Affinity DataKi:  1nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611900((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(2R)-2- hy...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611856((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611895((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611953((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611908(5-({[(2R,3R,11bR)-3-(2,2- dimethylpropyl)-2-hydrox...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611876((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(1- fluoro...)
Affinity DataKi:  1.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Rattus norvegicus (Rat))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Rattus norvegicus (Rat))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Rattus norvegicus (Rat))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  1.90nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611854((2R,3R,11bR)-9-(2,2- difluoroethoxy)-3-(2,2- dimet...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611950((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[2-(4- fluo...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611889(2-(2-{[(2R,3R,11bR)-3-(2,2- dimethylpropyl)-2-hydr...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611842((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  2.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Rattus norvegicus (Rat))
Neurocrine Biosciences

US Patent
LigandPNGBDBM516376(US11053242, Compound 1-1)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611855((2R,3R,11bR)-9-(2,2- difluoropropoxy)-3-(2,2- dime...)
Affinity DataKi:  2.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM50301021((+)-dihydrotetrabenzaine | CHEMBL576222 | US110532...)
Affinity DataKi:  2.60nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611909((2R,3R,11bR)-9-(benzyloxy)- 3-(2,2-dimethylpropyl)...)
Affinity DataKi:  3.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611853((2S,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  3.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611910((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(1- fluoro...)
Affinity DataKi:  3.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611911((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611883((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611912((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(4- fluoro...)
Affinity DataKi:  4.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611900((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(2R)-2- hy...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611888(2-(2-{[(2R,3R,11bR)-3-(2,2- dimethylpropyl)-2-hydr...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM516376(US11053242, Compound 1-1)
Affinity DataKi:  5.20nMAssay Description:Examples of techniques for determining the capability of a compound to inhibit VMAT2 are provided below. The procedure is adapted from that described...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611860((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(2- fluoroe...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611869((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(1- hydrox...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611913((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(3- fluoro...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611948((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  6.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  6.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611890(1-(2-{[(2R,3R,11bR)-3-(2,2- dimethylpropyl)-2-hydr...)
Affinity DataKi:  7.30nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611861((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-[(3- fluoro...)
Affinity DataKi:  8.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611914((2R,3R,11bR)-9-(2-chloro-2,2- difluoroethoxy)-3-(2...)
Affinity DataKi:  8.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611896((2R,3R,11bR)-9-(3,3-difluoro- 2-hydroxypropoxy)-3-...)
Affinity DataKi:  9.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicular amine transporter(Homo sapiens (Human))
Neurocrine Biosciences

US Patent
LigandPNGBDBM611915((2R,3R,11bR)-3-(2,2- dimethylpropyl)-10-methoxy- 9...)
Affinity DataKi:  10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1669 total ) | Next | Last >>
Jump to: